CIK 0001553643
- Non-accelerated filer
- Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 455401931
- Phone
- +1 646-876-3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- Open-market buys, last 90 days
- $1,671,990
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-09 | SCHMIDT ERIC THOMAS Director | Option exercise | +12,500 | $9.00 | $113K | 100,000 |
| 2020-04-09 | SCHMIDT ERIC THOMAS Director | Option exercise · Warrants to purchase common stock | −32,500 | $6.00 | $195K | 0 |
| 2020-04-09 | SCHMIDT ERIC THOMAS Director | Option exercise · Warrants to purchase common stock | −12,500 | $9.00 | $113K | 0 |
| 2020-03-17 | CASAMENTO CHARLES J Director | Gift | −21,484 | 40,000 | ||
| 2020-03-17 | CASAMENTO CHARLES J Director | Gift | +21,484 | 21,484 | ||
| 2019-12-24 | CASAMENTO CHARLES J Director | Option exercise | +46,484 | $3.24 | $151K | 46,484 |
| 2019-12-24 | CASAMENTO CHARLES J Director | Option exercise | +21,094 | $4.60 | $97K | 67,578 |
| 2019-12-24 | CASAMENTO CHARLES J Director | Shares withheld for taxes | −3,706 | $40.64 | $151K | 63,872 |
| 2019-12-24 | CASAMENTO CHARLES J Director | Shares withheld for taxes | −2,388 | $40.64 | $97K | 61,484 |
| 2019-12-24 | CASAMENTO CHARLES J Director | Option exercise · Options to purchase common stock | −46,484 | 59,766 | ||
| 2019-12-24 | CASAMENTO CHARLES J Director | Option exercise · Options to purchase common stock | −21,094 | 91,406 | ||
| 2019-12-19 | Ence Chuck CFO | Grant or award · Options to purchase common stock | +60,000 | $43.47 | $2.6M | 60,000 |
| 2019-12-19 | TRAVERSA SERGIO CEO | Grant or award · Options to purchase common stock | +350,000 | $43.47 | $15.2M | 350,000 |
| 2019-12-19 | Kelly Paul Edward Director | Grant or award · Options to purchase common stock | +150,000 | $43.47 | $6.5M | 150,000 |
| 2019-12-19 | CASAMENTO CHARLES J Director | Grant or award · Options to purchase common stock | +100,000 | $43.47 | $4.3M | 100,000 |
| 2019-12-19 | Vitolo Ottavio V. CMO | Grant or award · Options to purchase common stock | +105,000 | $43.47 | $4.6M | 105,000 |
| 2019-12-19 | Shenouda Maged Director | Grant or award · Options to purchase common stock | +120,000 | $43.47 | $5.2M | 120,000 |
| 2019-10-21 | Shenouda Maged Director | Purchase | +978 | $23.00 | $22K | 2,228 |
| 2019-10-18 | Kelly Paul Edward Director | Purchase | +1,000 | $18.99 | $19K | 123,121 |
| 2019-10-18 | Kelly Paul Edward Director | Purchase | +100 | $19.04 | $2K | 123,221 |
Page 15 of 19 · 370 trades